252 related articles for article (PubMed ID: 8601607)
1. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.
Vilquin JT; Kinoshita I; Roy B; Goulet M; Engvall E; Tomé F; Fardeau M; Tremblay JP
J Cell Biol; 1996 Apr; 133(1):185-97. PubMed ID: 8601607
[TBL] [Abstract][Full Text] [Related]
2. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
[TBL] [Abstract][Full Text] [Related]
3. CD90-positive cells, an additional cell population, produce laminin alpha2 upon transplantation to dy(3k)/dy(3k) mice.
Fukada S; Yamamoto Y; Segawa M; Sakamoto K; Nakajima M; Sato M; Morikawa D; Uezumi A; Miyagoe-Suzuki Y; Takeda S; Tsujikawa K; Yamamoto H
Exp Cell Res; 2008 Jan; 314(1):193-203. PubMed ID: 17963748
[TBL] [Abstract][Full Text] [Related]
4. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
5. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
[TBL] [Abstract][Full Text] [Related]
6. Laminin α1 reduces muscular dystrophy in dy
Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
Körner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M
Am J Pathol; 2014 May; 184(5):1518-28. PubMed ID: 24631023
[TBL] [Abstract][Full Text] [Related]
8. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
Nguyen Q; Lim KRQ; Yokota T
Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
[TBL] [Abstract][Full Text] [Related]
9. Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice.
Tiger CF; Gullberg D
Muscle Nerve; 1997 Dec; 20(12):1515-24. PubMed ID: 9390664
[TBL] [Abstract][Full Text] [Related]
10. The laminin alpha2 expressed by dystrophic dy(2J) mice is defective in its ability to form polymers.
Colognato H; Yurchenco PD
Curr Biol; 1999 Nov; 9(22):1327-30. PubMed ID: 10574769
[TBL] [Abstract][Full Text] [Related]
11. Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.
Vishnudas VK; Miller JB
Hum Mol Genet; 2009 Dec; 18(23):4467-77. PubMed ID: 19692349
[TBL] [Abstract][Full Text] [Related]
12. Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.
Guo LT; Zhang XU; Kuang W; Xu H; Liu LA; Vilquin JT; Miyagoe-Suzuki Y; Takeda S; Ruegg MA; Wewer UM; Engvall E
Neuromuscul Disord; 2003 Mar; 13(3):207-15. PubMed ID: 12609502
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin alpha2 chain gene.
Besse S; Allamand V; Vilquin JT; Li Z; Poirier C; Vignier N; Hori H; Guénet JL; Guicheney P
Neuromuscul Disord; 2003 Mar; 13(3):216-22. PubMed ID: 12609503
[TBL] [Abstract][Full Text] [Related]
14. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
15. Early skeletal muscle pathology and disease progress in the dy
Gawlik KI; Körner Z; Oliveira BM; Durbeej M
Sci Rep; 2019 Oct; 9(1):14324. PubMed ID: 31586140
[TBL] [Abstract][Full Text] [Related]
16. Antioxidants Reduce Muscular Dystrophy in the
Harandi VM; Oliveira BMS; Allamand V; Friberg A; Fontes-Oliveira CC; Durbeej M
Antioxidants (Basel); 2020 Mar; 9(3):. PubMed ID: 32197453
[TBL] [Abstract][Full Text] [Related]
17. Synaptic plasticity in the dy2J mouse model of laminin alpha2-deficient congenital muscular dystrophy.
Anderson JL; Head SI; Morley JW
Brain Res; 2005 Apr; 1042(1):23-8. PubMed ID: 15823249
[TBL] [Abstract][Full Text] [Related]
18. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
[TBL] [Abstract][Full Text] [Related]
19. Distribution of ten laminin chains in dystrophic and regenerating muscles.
Patton BL; Connoll AM; Martin PT; Cunningham JM; Mehta S; Pestronk A; Miner JH; Sanes JR
Neuromuscul Disord; 1999 Oct; 9(6-7):423-33. PubMed ID: 10545049
[TBL] [Abstract][Full Text] [Related]
20. A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD.
Gawlik KI; Durbeej M
Front Mol Neurosci; 2020; 13():59. PubMed ID: 32457577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
